Wie erkenne ich Demenz bei meinem Hund?

Kernzeichen: nächtliche Unruhe oder Heulen, zielloses Wandern, Desorientierung im Zuhause, Stubenunreinheit, Rückzug oder Erkennungsprobleme. Das DISHA-Schema (Disorientation, Interaction, Sleep, House soiling, Activity) hilft bei der Einschätzung. Bei Verdacht: Tierarztbesuch für Ausschlussdiagnostik.

Kann Demenz beim Hund behandelt werden?

Nicht heilbar, aber verlangsambar. Selegilin ist das einzige EMA-zugelassene Medikament für CDS und verbessert klinische Symptome. Ergänzend: Omega-3, mentale Stimulation (Nasenarbeit, Schnüffelspiele), strukturierter Alltag. Frühzeitige Therapie wirkt am besten.

In welchem Alter bekommt ein Hund Demenz?

Ab ~8–9 Jahren möglich, häufiger ab 12 Jahren. Großrassen altern schneller — CDS tritt dort früher auf. Körperliche und mentale Aktivität im mittleren Alter gelten als protektiv gegen frühen kognitiven Abbau.

Health & Diseases

Canine Dementia Syndrome (CDS): Symptoms, Diagnosis, and Treatment

Canine dementia — medically known as Canine Cognitive Dysfunction Syndrome (CDS) — is a neurodegenerative disease that, similar to Alzheimer's in humans, leads to a gradual decline in cognitive functions. It affects orientation, sleep-wake cycles, social interaction, memory, and house-training.

Auf einen Blick

Canine dementia — medically known as Canine Cognitive Dysfunction Syndrome (CDS) — is a neurodegenerative disease that, similar to Alzheimer's in humans, leads to a gradual decline in cognitive functions. It affects orientation, sleep-wake cycles, social interaction, memory, and house-training.
Risiko-Hinweis: low-moderate: Consider context and individual differences
Wissenschaftliche Einordnung: Landsberg et al. (2012, Veterinary Clinics of North America, PubMed 22980016) extensively described the pathophysiology and clinical picture: Amyloid-beta deposits in brain tissue, oxidative stress, and decreased cerebral blood flow are central findings in CDS dogs — structurally comparable to Alzheimer's pathology in humans. Selegiline (MAO-B inhibitor, increases dopamine levels) is the only approved medication for CDS in Europe and has shown improvement in clinical symptoms in studies.Azkona et al. (2009, Journal of Small Animal Practice, PubMed 19245609) investigated the prevalence and risk factors of cognitive impairment in geriatric dogs: In dogs over 10 years old, ~28% showed behavioral changes consistent with CDS; in dogs over 15 years old, the prevalence increased to over 68%. Physical activity and mental enrichment were protective — an indication of the importance of environmental stimulation even in old age.Madari et al. (2015, Applied Animal Behaviour Science, PubMed 25998248) developed and validated the CADES scale (CAnine DEmentia Scale): A standardized owner assessment tool that captures cognitive symptoms in four categories (spatial orientation, social interaction, sleep-wake cycle, house-training). CADES enables objective monitoring over time — important for progress control and therapy adjustment.

Canine Dementia (CDS): Symptoms, Diagnosis, and Treatment

What is dementia in dogs?

Dementia in dogs—medically known as Canine Cognitive Dysfunction Syndrome (CDS)—is a neurodegenerative disease that, much like Alzheimer’s disease in humans, leads to a gradual decline in cognitive function. It affects orientation, sleep-wake cycles, social interaction, memory, and house-training.

CDS is a disease of old age: it typically occurs in dogs around 8–9 years of age, with a marked increase in prevalence after 12 years. It is not a normal part of aging—it is a treatable condition in which early intervention can slow its progression.

Background + Scientific Context

Landsberg et al. (2012, Veterinary Clinics of North America, PubMed 22980016) provided a comprehensive description of the pathophysiology and clinical presentation: amyloid-beta deposits in brain tissue, oxidative stress, and reduced cerebral blood flow are key findings in dogs with CDS—structurally comparable to Alzheimer’s pathology in humans. Selegiline (an MAO-B inhibitor that increases dopamine levels) is the only approved medication for CDS in Europe and has been shown in studies to improve clinical symptoms.

Azkona et al. (2009, Journal of Small Animal Practice, PubMed 19245609) investigated the prevalence and risk factors of cognitive impairment in geriatric dogs: Among dogs over 10 years of age, approximately 28% exhibited behavioral changes consistent with CDS; among dogs over 15 years of age, the prevalence rose to over 68%. Physical activity and mental stimulation were protective factors—a suggestion of the importance of environmental stimulation even in old age.

Madari et al. (2015, Applied Animal Behaviour Science, PubMed 25998248) developed and validated the CADES scale (CAnine DEmentia Scale): A standardized owner-report assessment tool that measures cognitive symptoms across four categories (spatial orientation, social interaction, sleep-wake cycle, and house training). CADES enables objective monitoring over time—which is important for tracking progress and adjusting treatment.

Vitomalia-Position

Dementia in dogs is often dismissed as an inevitable part of aging. This is incorrect and harmful to the animal. CDS is diagnosable and treatable in its early stages—selegiline, an adapted environment, mental stimulation, and omega-3 supplementation can slow progression and maintain quality of life. Those who dismiss changes in older dogs as “normal” are missing out on valuable treatment opportunities.

When does dementia become a concern in dogs?

For older dogs that are restless at night, wander aimlessly, or howl
In cases of sudden house soiling with no medical cause (excluding bladder infection or incontinence )
If there are changes in social behavior: withdrawal, difficulty recognizing familiar people
If you feel disoriented in your own home or garden
In cases of a reversed sleep-wake cycle: sleeping during the day and being active at night

Practical application

DISHA mnemonic (clinical mnemonic for CDS symptoms):

Letter	English	Meaning
The	Disorientation	Disorientation, coming to a standstill, staring
In	Interaction changes	Social changes, withdrawal
S	Sleep-wake cycle	Sleep dysregulation, nighttime restlessness
He	House soiling	Housebreaking issues despite training
The	Activity changes	Apathy, reduced activity, hyperactivity

Steps to take if CDS is suspected: - Visit to the veterinarian: to rule out other causes (thyroid issues, pain, tumors, epilepsy) - Selegiline therapy: Prescription-only — recommended for early-stage CDS - Omega-3 fatty acids (EPA/DHA): supportive, help combat oxidative stress - Mental stimulation: Sniffing games, tailored nose work training - A structured daily routine: Predictability reduces anxiety

Common Mistakes & Myths

"That's just part of getting older—there's nothing you can do about it." CDS is a medical condition, not a normal part of aging. Early intervention measurably improves the prognosis. Waiting worsens the starting point for any treatment.
“My dog just sleeps a lot—that’s normal.” Sleep dysregulation (day-night reversal, nighttime wandering) is a core sign of CDS. Nighttime restlessness in older dogs should always be investigated.
“The dog is deliberately forgetting to be house-trained.” House-training issues in CDS are cognitively driven, not intentional. Punishment is doubly harmful: it increases stress and accelerates anxiety-related cognitive decline.

Current State of Research (2026)

Selegiline remains the only EMA-approved medication for dementia. Research on medium-chain triglycerides (MCTs), antioxidants, and cognitively stimulating diets is showing positive trends. Scintigraphy and MRI are improving ante-mortem diagnostics. Amyloid-beta biomarkers in cerebrospinal fluid are being investigated as a potential future early-detection test—though they are not yet a clinical standard.

Frequently Asked Questions

How can I tell if my dog has dementia?

Key signs: restlessness or howling at night, aimless wandering, disorientation at home, house soiling, changes in social behavior (withdrawal, difficulty recognizing people). The DISHA checklist can help with assessment. If you suspect this condition: visit a veterinarian for a differential diagnosis and, if necessary, selegiline therapy.

Can dementia in dogs be treated?

It cannot be cured, but its progression can be slowed. Selegiline (Anipryl/Selgian) is a prescription medication that improves clinical symptoms in CDS. Additional measures include omega-3 supplements, mental stimulation, and a structured daily routine. The earlier treatment begins, the greater the positive impact on the patient’s remaining quality of life.

At what age do dogs develop dementia?

Possible from around 8–9 years of age, but significantly more common from age 12 onward. Small breeds age more slowly than large breeds—CDS tends to develop earlier in large breeds. Physical activity and mental stimulation in middle age are considered protective factors.

Related terms

Sources & Further Reading

Landsberg, G. M., Nichol, J., & Araujo, J. A. (2012). Cognitive dysfunction syndrome: a disease of canine and feline brain aging. Veterinary Clinics of North America: Small Animal Practice, 42(4), 749–768. https://pubmed.ncbi.nlm.nih.gov/22980016/
Azkona, G., García-Belenguer, S., Chacón, G., Rosado, B., León, M., & Palacio, J. (2009). Prevalence and risk factors of behavioural changes associated with age-related cognitive impairment in geriatric dogs. Journal of Small Animal Practice, 50(2), 87–91. https://pubmed.ncbi.nlm.nih.gov/19245609/
Madari, A., Farbakova, J., Katina, S., Novak, M., Ferencik, M., Smolek, T., Zilka, N., & Bhide, M. (2015). Assessment of severity and progression of canine cognitive dysfunction syndrome using the CAnine DEmentia Scale (CADES). Applied Animal Behaviour Science, 171, 138–145. https://pubmed.ncbi.nlm.nih.gov/25998248/

Wissenschaftliche Einordnung

Landsberg et al. (2012, Veterinary Clinics of North America, PubMed 22980016) extensively described the pathophysiology and clinical picture: Amyloid-beta deposits in brain tissue, oxidative stress, and decreased cerebral blood flow are central findings in CDS dogs — structurally comparable to Alzheimer's pathology in humans. Selegiline (MAO-B inhibitor, increases dopamine levels) is the only approved medication for CDS in Europe and has shown improvement in clinical symptoms in studies.

Azkona et al. (2009, Journal of Small Animal Practice, PubMed 19245609) investigated the prevalence and risk factors of cognitive impairment in geriatric dogs: In dogs over 10 years old, ~28% showed behavioral changes consistent with CDS; in dogs over 15 years old, the prevalence increased to over 68%. Physical activity and mental enrichment were protective — an indication of the importance of environmental stimulation even in old age.

Madari et al. (2015, Applied Animal Behaviour Science, PubMed 25998248) developed and validated the CADES scale (CAnine DEmentia Scale): A standardized owner assessment tool that captures cognitive symptoms in four categories (spatial orientation, social interaction, sleep-wake cycle, house-training). CADES enables objective monitoring over time — important for progress control and therapy adjustment.